205 related articles for article (PubMed ID: 25544580)
1. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced immune-mediated cytopenias: a case report and literature review.
Forcello NP; Khubchandani S; Patel SJ; Brahaj D
J Oncol Pharm Pract; 2015 Apr; 21(2):148-56. PubMed ID: 24500808
[TBL] [Abstract][Full Text] [Related]
3. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
[TBL] [Abstract][Full Text] [Related]
4. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
Curtis BR; Kaliszewski J; Marques MB; Saif MW; Nabelle L; Blank J; McFarland JG; Aster RH
Am J Hematol; 2006 Mar; 81(3):193-8. PubMed ID: 16493620
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Drug-Induced Thrombocytopenia Resulting from Sensitivity to Oxaliplatin].
Masuda T; Nagai K; Sanada K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2157-9. PubMed ID: 26805296
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin-mediated autoimmune thrombocytopenia.
Saif MW; The A; Ledbetter L
Clin Colorectal Cancer; 2009 Jan; 8(1):61-2. PubMed ID: 19203900
[No Abstract] [Full Text] [Related]
7. Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature.
Bautista MA; Stevens WT; Chen CS; Curtis BR; Aster RH; Hsueh CT
J Hematol Oncol; 2010 Mar; 3():12. PubMed ID: 20346128
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
James E; Podoltsev N; Salehi E; Curtis BR; Saif MW
Clin Colorectal Cancer; 2009 Oct; 8(4):220-4. PubMed ID: 19822513
[TBL] [Abstract][Full Text] [Related]
9. Acute immune-mediated thrombocytopenia due to oxaliplatin administration: a case report.
Pietrantonio F; Di Bartolomeo M; Buzzoni R; Bajetta E
Tumori; 2010; 96(1):154-6. PubMed ID: 20437874
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-induced acute-onset thrombocytopenia, hemorrhage and hemolysis.
Koutras AK; Makatsoris T; Paliogianni F; Kopsida G; Onyenadum A; Gogos CA; Mouzaki A; Kalofonos HP
Oncology; 2004; 67(2):179-82. PubMed ID: 15539924
[TBL] [Abstract][Full Text] [Related]
12. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
Shao YY; Hong RL
Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced acute thrombocytopenia: a case report and review of the literature.
Suzuki K; Oda H; Sugawara Y; Masuya M; Nakase K; Fujioka M; Imai H; Katayama N
Intern Med; 2013; 52(5):611-5. PubMed ID: 23448774
[TBL] [Abstract][Full Text] [Related]
14. A rare hematological adverse event induced by bevacizumab: severe thrombocytopenia.
Dior M; Coriat R; Mir O; Brezault C; Perkins G; Dhooge M; Goldwasser F; Chaussade S
Am J Med; 2012 Aug; 125(8):828-30. PubMed ID: 22840668
[TBL] [Abstract][Full Text] [Related]
15. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin-induced immune pancytopenia.
Taleghani BM; Meyer O; Fontana S; Ahrens N; Novak U; Borner MM; Salama A
Transfusion; 2005 May; 45(5):704-8. PubMed ID: 15847658
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment continuation with a single mild partial splenic embolization for thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colon cancer.
Heianna J; Muto O; Miyauchi T; Endo W; Togashi A; Azama K; Murayama S
Indian J Gastroenterol; 2016 May; 35(3):245-7. PubMed ID: 27230031
[TBL] [Abstract][Full Text] [Related]
19. Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.
Waddle M; Irvin M; Gupta E; Gibbs M; Kakar TS; Gannon NA; Arthurs JR; Fischer DL; Ailawadhi S
Chemotherapy; 2017; 62(5):295-300. PubMed ID: 28505615
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.
Overman MJ; Maru DM; Charnsangavej C; Loyer EM; Wang H; Pathak P; Eng C; Hoff PM; Vauthey JN; Wolff RA; Kopetz S
J Clin Oncol; 2010 May; 28(15):2549-55. PubMed ID: 20406923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
